IP Library › Assignment 009586/0702
Patent Assignment
Reel/Frame 009586/0702

Change of Name

Recorded: 1998-11-02 Pages: 13
Assignor
Assignee
DUPONT PHARMACEUTICALS COMPANY
LEGAL DIVISION, CHESTNUT RUN PLAZA, 974 CENTRE ROAD, WILMINGTON, DELAWARE, 19805
Covered Properties (433)
4A-Aryl-Trans-Decahydroisoquinolines
Patent: 4,419,517 →
Application: 05/566,089 →
Antihypertensive Polyfluoroisopropyl Tricyclic Carbostyrils
Patent: 4,322,417 →
Application: 05/863,267 →
Reductant Composition for Technetium-99M and Method for Making Technetium-99M Labelled Ligands
Patent: 4,272,503 →
Application: 05/909,385 →
Denatured Albumin Complexes for Radioscintigraphic Imaging and Evaluation of Reticuloendothelial Systems
Patent: 4,337,240 →
Application: 06/018,312 →
Novel Forms of 5,5-Diphenylhydantoin Exhibiting Enhanced Solubility and the Therapeutic Use Thereof
Patent: 4,260,769 →
Application: 06/033,234 →
Analgesic Mixture of Nalbuphine and Acetaminophen
Patent: 4,237,140 →
Application: 06/040,281 →
Antiinflammatory 2-Substituted-1H-Phenanthro(9,10-D) Imidazoles
Patent: 4,215,135 →
Application: 06/045,671 →
Antidepressant Polycyclic Aziridines
Patent: 4,256,742 →
Application: 06/051,341 →
Octahydro-1H-Benzo(4,5)Furo(3,2-E)-Isoquinoline Analgesic and Narcotic Antagonistic Compounds
Patent: 4,243,668 →
Application: 06/054,447 →
Antiinflammatory 4,5-Diaryl-2-Nitroimidazoles
Patent: 4,251,535 →
Application: 06/084,630 →
Treating Pain with Acetaminophen and 1,4-Dimethyl-5-P-Chlorobenzoyl- Pyrrole-2- Acetic Acid
Patent: 4,260,629 →
Application: 06/088,119 →
Derivatives of 2-Amino-6, 7- Dihydroxytetrahydro Naphthalene (Adtn)
Patent: 4,314,082 →
Application: 06/114,531 →
Antibacterials:1-Difluoromethyl-6, 7-Methylenedioxy-1,4-Dihydro-4- Oxo-3-Quinolinecarboxylic Acid and Its Esters
Patent: 4,284,777 →
Application: 06/121,487 →
Antidepressant Pyrrolypiperidines, Theirpharmaceutical Compositions and Method of Use
Patent: 4,267,185 →
Application: 06/138,706 →
Antiinflammatory 4,5-Diaryla-Alpha,Alpaha-Bis(Polyfluoromethyl)-1H- Pyrrole-2-Methanethiols
Patent: 4,267,190 →
Application: 06/141,663 →
Variable Strength Beam Line Multipole Permanent Magnets and Methods for Their Use
Patent: 4,355,236 →
Application: 06/143,449 →
17-Substituted-6-Desoxy-7,8-Dihydro-6ALPHA-Methylnoroxymorphone Narcotic Antagonists
Patent: 4,322,426 →
Application: 06/144,542 →
Method of Using N-Substituted Dihydro-2-Oxazolamines as Analgesics
Patent: 4,256,755 →
Application: 06/144,543 →
Intermediates for the Preparation of Octahydro-1H-Benzo(4,5)Furo (3,2-E)-Isoquinoline Analgesic and Narcotic Antagonistic Compounds
Patent: 4,260,761 →
Application: 06/151,241 →
Antidepressant 2-Amino-and-2-(Substituted Amino)-Cis-Hexahydro-Carba- Zoles, Compositions and Use
Patent: 4,343,812 →
Application: 06/155,977 →
Method and System for Generating and Collecting Gallium-68 Using Alkaline Eluant
Patent: 4,330,507 →
Application: 06/158,395 →
Analgesic Mixutre of Nalbuphine and Acetylsalicyclic Acid, Derivative or Salt Thereof
Patent: 4,282,215 →
Application: 06/170,931 →
1,2,3,4A,5,10,10A-Octahydro-5G10-Ortho-Benzenobenz[G]Isoquinolines and Antidepressant Use Thereof
Patent: 4,351,836 →
Application: 06/172,991 →
2-Substitutedthio-4,5-Diarylpyrimidines
Patent: 4,438,117 →
Application: 06/183,336 →
Antiinflammatory 2-Substituted -Thio-4,5- Dihydro-4,5-Diaryl-1H-Imidazoles
Patent: 4,379,159 →
Application: 06/197,750 →
3-(P-Alkylsulfonylphenyl) Oxazolidinone Derivatives as Antibacterial Agents
Patent: 4,340,606 →
Application: 06/199,698 →
Antihypertensive 1-Substituted Cyclic Lactam-2-Carboxylic Acids
Patent: 4,296,110 →
Application: 06/201,471 →
Antiinflammatory 4,5-Diaryl-2-Arylthioimidazoles
Patent: 4,330,552 →
Application: 06/204,569 →
Unit Dose Drug Control Package
Patent: 4,340,141 →
Application: 06/237,458 →
Antiinflammatory 4,5-Diaryl-Alpha-(Polyfluoroalkyl)-1H-Pyrrole-2- Methanamines
Patent: 4,335,136 →
Application: 06/237,638 →
Antiinflammatory 4,5-Diaryl-1H-Imidazole-2-Methanols
Patent: 4,372,964 →
Application: 06/294,747 →
Antiinflammatory 4, 5-Diaryl-Alpha-(POLYHALOMETHY1)-2-Thiopheneme- Thanols
Patent: 4,381,311 →
Application: 06/295,781 →
Variable Strength Focusing of Permanent Magnet Quadrupoles While Eliminating X-Y Coupling
Patent: 4,429,229 →
Application: 06/296,550 →
Cationic Compounds Useful for Making Radiodiagnostic Agents
Patent: 4,451,450 →
Application: 06/311,770 →
Aromatic Acid Esters of Hydroxypropylamines
Patent: 4,582,855 →
Application: 06/320,773 →
4,5-Bis-(4-Fluorophenyl)-1-(4-Nitrobenzyl)-2-((1,1,2,2- Tetrafluoroethyl)Sulfonyl)-1H-Imidazole,Composition and Use
Patent: 4,355,041 →
Application: 06/336,764 →
Antiinflammatory and/or Analgesic 3,4-Dihydro- (or 1,4-Dihydro)-4- Aryl-2-((Substituted)Thio)-(1)-Benzopyrano(3,4-D)Imidazoles and Their Corresponding Sulfoxides and Sulfones
Patent: 4,371,541 →
Application: 06/336,822 →
Antiinflammatory and/or Analgesic 1,8-Dihydro-(or 3,8-Dihydro)-8- Aryl-2-((Substituted)Thio)-Indeno(1,2-D)Imidazoles and Their Corresponding Sulfoxides and Sulfones
Patent: 4,548,946 →
Application: 06/349,201 →
Phthalazine Compounds,Composition and Use
Patent: 4,466,965 →
Application: 06/401,752 →
Method for Forming Cationic Technetium Complexes Useful as Radiodiagnostic Agents
Patent: 4,497,790 →
Application: 06/414,608 →
Heparin Compositions Freed of Mineral Salts, Particularly Oxalates, and Process for Obtaining Same
Patent: 4,652,555 →
Application: 06/452,197 →
Parenteral Infusion of Nitroglycerin Solutions
Patent: 4,850,981 →
Application: 06/460,616 →
4-Aryl-4-Piperidinecarbinols
Patent: 4,485,109 →
Application: 06/468,040 →
Cationic Cyanato and Thiocyanato Complexes Useful as Radiodiagnostic Agents
Patent: 4,526,776 →
Application: 06/485,217 →
Trace-Labeled Conjugates of Metallothionein and Target-Seeking Biologically Active Molecules
Patent: 4,732,864 →
Application: 06/539,733 →
Alpha-Aminoboronic Acid Peptides
Patent: 4,499,082 →
Application: 06/558,362 →
P-Oxooxazolidinylbenzene Compounds as Antibacterial Agents
Patent: 4,461,773 →
Application: 06/567,411 →
Antiinflammatory and/or Analgesic 2,3-Diaryl-5-Halo Thiophenes
Patent: 4,590,205 →
Application: 06/570,450 →
2,3-Diaryl-5-Bromothiophene Compounds of Use for the Treatment of Inflammation and Dysmenorrhea
Patent: 4,820,827 →
Application: 06/577,650 →
Preparation of Optically Active 1,3-Dioxolane-4-Methanol Compounds
Patent: 4,575,558 →
Application: 06/580,492 →
Antiinflammatory and/or Analgesic 5-Alkylthiophenes
Patent: 4,749,712 →
Application: 06/678,680 →
Phenylquinazolinecarboxylic Acids and Derivatives as Cancer Chemotherapeutic Agents
Patent: 4,639,454 →
Application: 06/692,412 →
Analgesic Mixture of Narcotic Analgesics and Ibuprofen
Patent: 4,569,937 →
Application: 06/700,654 →
2-Phenyl-4-Quinolinecarboxylic Acids and Pharmaceutical Composition Thereof
Patent: 4,680,299 →
Application: 06/727,808 →
Pharmaceutical Compositions Containing Hollow Fine Tubular Drug Delivery Systems
Patent: 4,673,565 →
Application: 06/730,064 →
Substituted Benzoate Ester Prodrug Derivatives of 3-Hydroxymorphinans, Which Are Analgesics or Narcotic Antagonists
Patent: 4,668,685 →
Application: 06/733,464 →
Trandermal Delivery of Opioids
Patent: 4,626,539 →
Application: 06/741,762 →
Intermediates for Octahydrobenzofuro(3,2-E)Isoquinolines
Patent: 4,692,528 →
Application: 06/743,415 →
Imide Intermediates for the Preparation of Analgesic and/or Antagonist Octahydrobenzofuroisoquinolines
Patent: 4,751,306 →
Application: 06/774,025 →
Perfusate for the Preservation of Organs
Patent: 4,798,824 →
Application: 06/784,435 →
Protective Sheath Cover for a Hypodermic Syringe Needle
Patent: 297,570 →
Application: 06/793,879 →
Aminomethyl Oxooxazolidinyl Benzenes Useful as Antibacterial Agents
Patent: 4,705,799 →
Application: 06/803,191 →
Optically Active Aryloxypropanolamines and Arylethanolamines
Patent: 4,990,668 →
Application: 06/804,407 →
Aryl Substituted Aminomethyl Benzene Derivatives
Patent: 4,755,527 →
Application: 06/813,732 →
2-Substituted-1-Naphthols Pharmaceutical Compositions of,and Their Use as 5-Lipoxygenase Inhibitors
Patent: 4,833,164 →
Application: 06/839,912 →
Substituted Acenaphthenes and Their Use as Inhibitors of Phospholipase A2
Patent: 4,806,671 →
Application: 06/860,428 →
Use of Prodrugs of 3-Hydroxymorphinans to Prevent Bitter Taste Upon Buccal, Nasal or Sublingual Administration
Patent: 4,673,679 →
Application: 06/863,045 →
Metal-Isonitrile Adducts for Preparing Radionuclide Complexes
Patent: 4,894,445 →
Application: 06/880,349 →
New Substituted-3-Phenoxy-1-Alkoxycarbonyl-Alkylamino-Propanol-2-S Having Beta Receptor Blocking Properties
Application: 06/885,733 →
Azapropazone Prevention of Post-Ischemic Tissue Damage
Patent: 4,668,676 →
Application: 06/885,766 →
Pseudorabies Virus Recombinants and Their Use in the Production of Proteins
Patent: 5,037,742 →
Application: 06/886,691 →
Manufacture of Hollow Fine Tubular Drug Delivery Systems
Patent: 4,720,384 →
Application: 06/898,653 →
Process for the Preparation of 2-(1-Hydroxyalkyl)-5,5- Diphenylhydantoin
Patent: 4,709,042 →
Application: 06/909,140 →
3,3-Disubstituted Indolines
Patent: 4,760,083 →
Application: 06/944,953 →
A Method of Using Phenylquinolinecarboxylic Acids and Derivatives for Lymphoid Leukemia Treatment in a Mammal
Patent: 5,032,597 →
Application: 07/030,421 →
Site-Specific Recombination of Dna in Eukaryotic Cells
Patent: 4,959,317 →
Application: 07/043,795 →
Ether Isonitriles and Radiolabeled Complexes Thereof
Patent: 4,988,827 →
Application: 07/056,003 →
Freeze-Dried Pharmaceutical Compositions of Phenylquinoline Carboxylic Acids
Patent: 4,889,862 →
Application: 07/060,203 →
Benzo-Fused Cycloalkane Trans-1,2-Diamine Derivatives
Patent: 4,876,269 →
Application: 07/071,028 →
Tris(Isonitrile)Copper(I) Adducts for Preparing Radionuclide Complexes
Patent: 4,885,100 →
Application: 07/095,924 →
Aminomethyl Oxooxazolidinyl Cycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,801,600 →
Application: 07/106,358 →
3,3-Disubstituted Indolines
Patent: 4,876,259 →
Application: 07/129,150 →
Antifungal Carbinols
Patent: 4,952,232 →
Application: 07/134,261 →
Ester-Substituted Diaminedithiols and Radiolabeled Complexes Thereof
Patent: 5,279,811 →
Application: 07/143,561 →
Peptide Boronic Acid Inhibitors of Trypsin-Like Proteases
Patent: 5,187,157 →
Application: 07/178,368 →
4-Quinoline Carboxylic Acid Derivatives Useful for Treating Skin and Muco-Epithelial Diseases
Patent: 4,861,783 →
Application: 07/186,242 →
4-Quinoline Carboxylic Acid Derivatives Useful as Immunosuppressive Agents
Patent: 4,968,701 →
Application: 07/186,243 →
Monoclonal Antibodies to Tissue Plasminogen Activator (T-Pa) Which Prolong Its Functional Half-Life
Patent: 5,225,540 →
Application: 07/186,277 →
Aminomethyloxooxazolidinyl Arylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,948,801 →
Application: 07/225,809 →
Antiinflammatory Carbinoloimidazoles
Patent: 4,859,693 →
Application: 07/230,448 →
Aminomethyl Oxooxazolidinyl Cycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,921,869 →
Application: 07/233,828 →
Alpha, Alpha-Disubstituted Aromatics and Heteroaromatics as Cognition Enhancers
Patent: 5,173,489 →
Application: 07/234,382 →
Antihypercholesterolemic 4,5-Diaryl-2-Substituted Thioimidazoles
Patent: 4,900,744 →
Application: 07/244,170 →
Dot Matrix Membrane Cell Expansion and Maintenance Vessel
Patent: 5,068,195 →
Application: 07/266,876 →
Substituted Indole, Benzofuran and Benzothiophene Derivatives as 5- Lipoxygenase Inhibitors
Patent: 5,093,351 →
Application: 07/293,522 →
3-Phenyl-5,6-Dihydrobenz(C)Acridine-7-Carboxylic Acids and Related Compounds as Cancer Chemotherapeutic Agents
Patent: 4,918,077 →
Application: 07/301,379 →
Labeled Cryopreserved Cells for Use as Targets in Cytotoxicity Assays
Patent: 4,983,515 →
Application: 07/311,513 →
Il-2 Analogs Containing N-Linked Glycosylation Sites
Patent: 5,153,310 →
Application: 07/317,177 →
2-Hydroxypropylamine Aryl Ester Derivatives and Pharamaceutical Use
Patent: 4,935,421 →
Application: 07/318,147 →
1(2H)-Isoquinolinones and 1-Isoquinolineamines as Cancer Chemotherapeutic Agents
Patent: 4,942,163 →
Application: 07/322,191 →
Human Immunodeficiency Virus (Hiv) Env-Coded Peptide Capable of Eliciting Hiv-Inhibiting Antibodies in Mammals
Patent: 5,562,905 →
Application: 07/324,027 →
2-Substituted-1-Naphthols as 5-Lipoxygenase Inhibitors
Patent: 4,906,636 →
Application: 07/324,533 →
2-Substituted-1-Naphthols as 5-Lipoxygenase Inhibitors
Patent: 4,985,435 →
Application: 07/324,534 →
2-Substituted-1-Naphthols as 5-Lipoxygenase Inhibitors
Patent: 4,985,442 →
Application: 07/327,717 →
Process for Purifying Nucleoside-5'-Diphosphates
Patent: 5,109,125 →
Application: 07/335,122 →
Stable Pharmaceutical Composition of 3-(Hydroxymethyl)-5,5- Diphenylhydantoin Disodium Phosphate Ester
Patent: 4,925,860 →
Application: 07/356,948 →
Diagnostic Assay for Alzheimer's Disease
Patent: 5,234,814 →
Application: 07/359,822 →
Intranasal Administration of 3,3-Disubstituted Indolines
Patent: 4,965,066 →
Application: 07/362,284 →
Benzo-Fused Cycloalkane and Oxa- and Thia-, Cycloalkane Trans-1,2- Diamine Derivatives
Patent: 4,929,627 →
Application: 07/362,681 →
Aminomethyl Oxooxazolidinyl Aroylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,942,183 →
Application: 07/376,456 →
Aminomethyl Oxooxazolidinyl Ethenylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,977,173 →
Application: 07/376,457 →
Benzylketone Phospholipase A2 Inhibitors
Patent: 4,948,813 →
Application: 07/386,530 →
Antiinflammatory PLA2 Inhibitors
Patent: 5,039,706 →
Application: 07/386,925 →
Benzylalcohol Phospholipase A2 Inhibitors
Patent: 5,124,334 →
Application: 07/387,319 →
Inhibition of Hiv and Other Retroviruses by Polyoxoanions
Patent: 5,051,414 →
Application: 07/389,030 →
N-Oxide Prodrug Derivatives of 3-Hydroxy Morphinans and Partial Morphinans and Derivatives
Patent: 4,990,617 →
Application: 07/391,406 →
Process for Preparing Tc-99M Tris (Isonitrile) Copper Complexes
Patent: 5,028,699 →
Application: 07/397,528 →
Tris(Isonitrile)Copper(I) Adducts for Preparing Radionuclide Complexes
Patent: 5,008,418 →
Application: 07/397,529 →
4-Aryl-4-Piperidine (or Pyrrolidine or Hexahydroazepine) Carbinols and Heterocyclic Analogs Thereof
Patent: 5,086,063 →
Application: 07/398,996 →
4-Aryl-4-Piperidine (or Pyrrolidine or Hexahydroazepine) Carbinols and Heterocyclic Analogs Thereof
Patent: 5,019,650 →
Application: 07/398,999 →
Topical Antiinflammatory Compositions with Minimal Systemic Absorption
Patent: 5,091,379 →
Application: 07/400,404 →
Oral Anticoagulant/Platelet Inhibitor Low Dose Formulation
Patent: 5,041,430 →
Application: 07/408,394 →
Antifungal Carbinols
Patent: 4,980,367 →
Application: 07/423,243 →
Antifungal Carbinols
Patent: 4,965,280 →
Application: 07/423,250 →
Antifungal Carbinols
Patent: 4,965,281 →
Application: 07/423,256 →
Pseudorabies Virus Recombinants and Their Use in the Production of Proteins
Patent: 5,004,693 →
Application: 07/424,784 →
2-Substituted-1-Naphthols as 5-Lipoxygenase Inhibitors
Patent: 5,026,759 →
Application: 07/445,776 →
Benzo-Fused Cycloalkane and Oxa- and Thia-Cycloalkane Trans-1,2- Diamine Derivatives
Patent: 5,010,085 →
Application: 07/455,882 →
Benzo-Fused Cycloalkane and Oxa- and Thia-, Cycloalkane Trans-1,2- Diamine Derivatives
Patent: 5,043,350 →
Application: 07/455,887 →
4,4'-(9H-Fluoren-9-Ylidenebis (Methylene) )-Bispyrimidine for Treating Neurological Disorders
Patent: 5,087,628 →
Application: 07/464,433 →
Esters of 2-Arylmethyl -1-Naphthol Derivatives as 5-Lipoxygenase Inhibitors
Patent: 5,006,555 →
Application: 07/466,601 →
Pyridylphenyl Nitrogen Heterocycle-Substituted Carbinols and Derivatives Thereof with Anti-Inflammatory Activity
Patent: 5,049,570 →
Application: 07/469,854 →
Porous Substrates with a High Concentration of Amine Groups
Patent: 5,164,475 →
Application: 07/473,071 →
Benzothienobenzacridine-7-Carboxylic Acids as Cancer Chemotherapeutic Agents
Patent: 5,002,954 →
Application: 07/473,507 →
Method and Compositions to Screen Compounds for Enhancement of the Cholinergic, Dopaminergic and Serotonergic Function
Patent: 5,278,045 →
Application: 07/486,484 →
Aminomethyl Oxooxazolidinyl Cycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,985,429 →
Application: 07/497,211 →
Aminomethyl Oxooxazolidinyl Oxa or Thia Cycloalkybenzene Derivatives Useful as Antibacterial Agents
Patent: 5,032,605 →
Application: 07/497,212 →
Aminomethyl Oxooxazolidinyl Cycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 4,965,268 →
Application: 07/497,213 →
Aminomethyl Oxooxazolidinyl Azacycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 5,036,093 →
Application: 07/497,214 →
Aminomethyl Oxooxazolidinyl Azacycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 5,036,092 →
Application: 07/497,215 →
Aminomethyl Oxooxazolidinyl Oxa or Thia Cycloalkylbenzene Derivatives Useful as Antibacterial Agents
Patent: 5,039,690 →
Application: 07/497,216 →
N-Aralkyl Piperidine Derivatives as Psychotropic Drugs
Patent: 5,116,846 →
Application: 07/500,573 →
Piperidine Ether Derivatives as Psychotropic Drugs or Plant Fungicides
Patent: 5,169,855 →
Application: 07/506,961 →
Oligonucleotide Analogs with Sulfamate Linkages
Patent: 5,470,967 →
Application: 07/507,693 →
Stable Human Cell Lines Expressing an Indicator Gene Product Under Virus-Specific Genetic Controls
Patent: 5,026,635 →
Application: 07/515,132 →
Benzylketone Phospholipase A2 Inhibitors
Patent: 5,075,339 →
Application: 07/531,653 →
Use of Imidazoles for the Treatment of Atherosclerosis
Patent: 5,166,214 →
Application: 07/533,241 →
Treatment of Organ Transplantation Rejection
Patent: 5,204,329 →
Application: 07/535,672 →
Bis-Naphthalimides as Anticancer Agents
Patent: 5,086,059 →
Application: 07/539,115 →
Clipsin, a Chymotrypsin-Like Protease and Method of Using Same
Patent: 5,252,463 →
Application: 07/543,618 →
4-Quinoline Carboxylic Acid Derivatives Useful as Immunosuppressive Agents
Patent: 5,084,462 →
Application: 07/545,048 →
3-Phenyl-5,6-Dihydrobenz(C) Acridine-7-Carboxylic Acids and Related Compounds as Immunosuppressive Agents
Patent: 5,135,934 →
Application: 07/548,825 →
2-Amino-1,4-Dihydropyridine Derivatives with Calcium Agonist and ALPHA1-Antagonist Activity
Patent: 5,166,148 →
Application: 07/549,820 →
4-Heteroaryl-And 4-Aryl-1,4-Dihydropyridine, Derivatives with Calcium Agonist and ALPHA1-Antagonist Activity
Patent: 5,166,147 →
Application: 07/549,821 →
Method of Treating Neurological Dysfunction Using Neurotransmitter Enhancers
Patent: 5,171,745 →
Application: 07/552,216 →
Aminomethyloxooxazlidinyl Arylbenzene Derivatives Useful as Antibacterial Agents
Patent: 5,130,316 →
Application: 07/558,129 →
Aminomethyloxooxazolidinyl Arylbenzene Derivatives
Patent: 5,043,443 →
Application: 07/558,131 →
Antipsychotic 1-Cycloalkylpiperidines
Patent: 5,109,002 →
Application: 07/570,199 →
Steroid Derivatives Useful as Hypocholesterolemics
Patent: 5,041,432 →
Application: 07/589,012 →
Ether Derivatives of Alkyl Piperidines and Pyrrolidines as Anti- Psychotic Agents
Patent: 5,252,586 →
Application: 07/589,863 →
Sterilizable Radionuclide Generator and Method for Sterilizing the Same
Patent: 5,109,160 →
Application: 07/596,273 →
Steroid Derivatives Useful as Hypocholesterolemics
Patent: 5,034,548 →
Application: 07/596,378 →
Antifungal Carbinols
Patent: 5,084,465 →
Application: 07/602,341 →
Vinylogous Hydroxamic Acids and Derivatives Thereof as 5-Lipoxygenase Inhibitors
Patent: 5,110,831 →
Application: 07/621,152 →
(Amidomethyl)Nitrogen Heterocyclic Analgesics
Patent: 5,254,569 →
Application: 07/640,561 →
Dry Powder Composition of Hydroxyethyl Starch Suitable for Reconstitution
Patent: 5,704,297 →
Application: 07/652,034 →
Use of Sigma Receptor Antagonists for Treatment of Amphetamine Abuse
Patent: 5,162,341 →
Application: 07/659,443 →
Use of Sigma Receptor Antagonists for Treatment of Cocaine Abuse
Patent: 5,180,729 →
Application: 07/659,444 →
Heterocyclic Steroid Compounds
Patent: 5,219,879 →
Application: 07/664,988 →
Metal-Isonitrile Adducts for Preparing Radionuclide Complexes
Patent: 5,324,824 →
Application: 07/670,458 →
Purification of Active and Inactive/Latent Forms of Plasminogen Activator Inhibitor-1
Patent: 5,260,419 →
Application: 07/671,433 →
Bis-Naphthalimides Containing Amide and Thioamide Linkers as Anticancer Agents
Patent: 5,206,250 →
Application: 07/676,062 →
Use of Sigma Receptor Antagonists to Enhance the Effects of Antipsychotic Drugs
Patent: 5,231,099 →
Application: 07/685,749 →
Porous Inorganic Ultrasound Contrast Agents
Patent: 5,147,631 →
Application: 07/693,476 →
1,4-Diamino-2,3-Dihydroxybutanes
Patent: 5,294,720 →
Application: 07/714,042 →
Dot Matrix Membrane Cell Expansion
Patent: 5,139,946 →
Application: 07/725,148 →
Inhibition of Hiv and Other Retroviruses by Polyoxoanions
Patent: 5,093,327 →
Application: 07/730,981 →
Amantadine Hydrochloride Suspension with Enhanced Dissolution Characteristics for Use in Soft Gelatin Capsules
Patent: 5,175,002 →
Application: 07/770,461 →
Technetium-99M Complexes with N-Substituted 3-Hydroxy-4-Pyridinones
Patent: 5,336,482 →
Application: 07/804,315 →
Bis-Naphthalimides Containing Amino-Acid Derived Linkers as Anticancer Agents
Patent: 5,206,249 →
Application: 07/805,044 →
5H-(1,2)Benzisothiazolo(2,3-A)Quinoline-5-Ones and Analogs as Antiinflammatory Agents
Patent: 5,225,418 →
Application: 07/808,712 →
Antihypercholesterolemic 2-Substituted Imidazoles
Patent: 5,179,117 →
Application: 07/811,213 →
Process for the Preparation of Tertiary Carbinamines
Patent: 5,306,821 →
Application: 07/819,429 →
Therapeutic Utility of Plasminogen Activator Inhibitor-1 to Control Bleeding
Patent: 5,254,536 →
Application: 07/820,013 →
Stabilization of Active Plasminogen Activator Inhibitor-1
Patent: 5,290,764 →
Application: 07/820,523 →
Disubstituted Polycyclic Systems and Preparative Methods Therefor
Patent: 5,272,269 →
Application: 07/821,571 →
Polycyclic Ketones and Preparative Methods Therefor
Patent: 5,185,447 →
Application: 07/827,429 →
Antipsychotic 1-Cycloalkylpiperidines
Patent: 5,243,048 →
Application: 07/831,886 →
Treatment of Psychosis Using 1-Cycloalkylpiperidines
Patent: 5,296,479 →
Application: 07/831,887 →
Hydroisoindolines and Hydroisoquinolines as Psychotropic
Patent: 5,216,018 →
Application: 07/836,229 →
Antipsychotic Nitrogen-Containing Bicyclic Compounds
Patent: 5,532,243 →
Application: 07/836,230 →
Antihypercholesterolemic Bis-Trifluoromethyl-Substituted Imidazolines and Derivatives Thereof
Patent: 5,428,041 →
Application: 07/836,323 →
Peptide Boronic Acid Inhibitors of Trypsin-Like Proteases
Patent: 5,242,904 →
Application: 07/848,296 →
Intermediates for Preparing Peptide Boronic Acid Inhibitors of Trysp- Sin-Like Proteases
Patent: 5,250,720 →
Application: 07/852,023 →
(N-Benzyl) Acetaldehyde Bicyclic Heterocycles Useful as Topical Antiinflammatories
Patent: 5,217,983 →
Application: 07/860,775 →
Imidazoles Linked to Bicyclic Heterocyclic Groups for the Treatment of Atherosclerosis
Patent: 5,364,875 →
Application: 07/881,033 →
Fused-Ring Heterocycles for the Treatment of Atherosclerosis
Patent: 5,478,830 →
Application: 07/889,892 →
Heterocycle-Substituted Amides, Carbamates and Ureas with Polyether and Polyamine Linkages as Agents for the Treatment of Atherosclerosis
Patent: 5,358,946 →
Application: 07/889,896 →
For the Treatment of Atherosclerosis Benaimidazoles
Patent: 5,290,801 →
Application: 07/889,909 →
Amantadine Hydrochloride Suspension with Enhanced Dissolution Characteristics for Use in Soft Gelatin Capsules
Patent: 5,275,821 →
Application: 07/892,146 →
3-Phenyl-5,6-Dihydrobenz[C]Acridine-7-Carboxylic Acids and Related Compounds as Immunosuppressive Agents
Patent: 5,190,753 →
Application: 07/892,165 →
Substituted Naphthofurans as Anti-Inflammatory Agents
Patent: 5,244,917 →
Application: 07/893,409 →
Substituted 1-Benzylindanes and Their Use as Inhibitors of Phospholipase A2
Patent: 5,290,817 →
Application: 07/895,688 →
Antipsychotic 1-Cycloalkylpiperidines
Patent: 5,266,572 →
Application: 07/900,774 →
Etanidazole Injectable Solution
Patent: 5,192,784 →
Application: 07/906,022 →
Monoamine Oxidase-B (Mao-B) Inhibitory 5-Substituted 2,4-Thiazolidinediones Useful in Treating Memory Disorders of Mammals
Patent: 5,326,770 →
Application: 07/913,963 →
Alkyl and Alkylbenzyl Ethers of Substituted Hydroquinones
Patent: 5,380,755 →
Application: 07/918,836 →
Pyridoindolobenzodiazepines and Deriviatives as Antipsychotics
Patent: 5,321,023 →
Application: 07/921,051 →
Aminomethyloxooxazolidinyl Arylbenzene Derivatives Useful as Antibacterial Agents
Patent: 5,254,577 →
Application: 07/929,452 →
3,3'-Disubstituted-1,3-Dihydro-2H-Pyrrolo[2,3-B]Heterocyclic-2-One Useful in the Treatment of Cognitive Disorders of Man
Patent: 5,278,162 →
Application: 07/947,152 →
Alpha,Alpha-Disubstituted Aromatics and Heteroaromatics as Cognition Enhancers
Patent: 5,434,264 →
Application: 07/953,273 →
Alpha, Alpha-Disubstituted Aromatics and Heteroaromatics as Cognition Enhancers
Patent: 5,300,642 →
Application: 07/953,274 →
1-Substituted Oxindoles as Cognition Enhancers
Patent: 5,296,478 →
Application: 07/957,152 →
2-Amino-1, 4-Dihydropyridine Derivatives with Calcium Agonist and Alphlal-Antagonist Activity
Patent: 5,314,887 →
Application: 07/968,933 →
Angiotensin-Ii Receptor Blocking, Azacycloalkyl or Azacycloalkenyl
Patent: 5,376,666 →
Application: 07/983,307 →
Radiolabelled Complexes of Ester-Substituted Diaminethiols
Patent: 5,688,485 →
Application: 07/999,705 →
Unsymmetrical Mono-3-Nitro Bis-Naphthalimides as Anticancer Agents
Patent: 5,376,664 →
Application: 08/016,553 →
Unsymmetrical Bis-Imides as Anticancer Agents
Patent: 5,359,070 →
Application: 08/016,555 →
Method for Detecting the Cardiotoxicity of Compounds
Patent: 5,604,112 →
Application: 08/023,396 →
As Process of Preparing Tetraamino Intermediates
Patent: 5,329,048 →
Application: 08/025,633 →
Hydroisoindolines and Hydroisoquinolines as Psychotropic Drugs
Patent: 5,409,929 →
Application: 08/028,774 →
Removal of Boronic Acid Protecting Groups by Transesterification
Patent: 5,384,410 →
Application: 08/036,378 →
Substituted 1,4 Diazapine Caprolactams Useful for Treatment of Hiv Disease
Patent: 5,663,333 →
Application: 08/040,324 →
Radiolabeled Platelet Gpiib/Iiia Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
Application: 08/040,336 →
Substituted 2,5-Diaryl-4-Isothiazolin-3-Ones as Antinflammatory and Antithrombotic Agents
Patent: 5,411,977 →
Application: 08/040,771 →
5H-[1,2]Benzisothiazolo[2,3-A]Quinoline-5-Ones and Analogs as Antiinflammatory Agents
Patent: 5,393,756 →
Application: 08/051,611 →
Bispyridyl-Containing Heterocycles Useful for Treating Cognitive Disorders
Patent: 5,308,851 →
Application: 08/070,826 →
Immunoassay Reagents and Methods for Detecting Brequinar and Analogs
Patent: 5,393,891 →
Application: 08/072,641 →
Imidazole 5-Position Substituted Angiotensin Ii Antagonists
Patent: 5,395,844 →
Application: 08/072,977 →
Polycyclic and Heterocyclic Chromophores for Bis-Imide Tumoricidals
Patent: 5,416,089 →
Application: 08/080,862 →
Tris(Isonitrile)Copper(I) Sulfates for Preparing Radionuclide Complexes
Patent: 5,420,321 →
Application: 08/098,442 →
Method of Treating Human Immunodeficiency Virus Infection Using a Cyclic Protease Inhibitor in Combination with a Reverse Transcriptase Inhibitor
Patent: 5,616,578 →
Application: 08/110,603 →
Carbocyclic Fused-Ring Quinolinecarboxylic Acids Useful as Immunosuppressive Agents
Patent: 5,428,040 →
Application: 08/114,712 →
Disubstituted Polycyclic Systems and Preparative Methods Therefor
Patent: 5,424,430 →
Application: 08/117,211 →
Novel Neurotransmitter Releasers Useful for Cognition Enhancement
Patent: 5,414,004 →
Application: 08/124,523 →
Dipeptide Boronic Acid Inhibitors of Trypsin-Like Enzymes
Patent: 5,462,964 →
Application: 08/139,444 →
Ester-Substituted Diaminedithiols and Radiolabeled Complexes Thereof
Patent: 5,431,900 →
Application: 08/139,894 →
Intermediates for the Synthesis of Anthrapyrazolone Anticancer Agents
Patent: 5,393,886 →
Application: 08/142,635 →
Aromatic Compounds Containing Basic and Acidic Termini Useful as Fibrinogen Receptor Antagonists
Patent: 5,523,302 →
Application: 08/157,860 →
1,4-Diamine-2,3-Dihydroxy Butanes
Patent: 5,430,155 →
Application: 08/167,659 →
Apparatus and Method for the Preparation of a Radiopharmaceutical Formulation
Patent: 5,397,902 →
Application: 08/167,685 →
Substituted Bicyclic Phosphoramides and Derivatives Thereof
Patent: 5,543,517 →
Application: 08/181,117 →
1-Substituted Azaoxindoles and Pharmaceutical Compostions
Patent: 5,428,035 →
Application: 08/191,416 →
Substituted Cyclic Carbonyls and Derivatives Thereof Useful as Retroviral Protease Inhibitors
Patent: 5,610,294 →
Application: 08/197,630 →
Crosslinked Polymeric Ammonium Salts
Patent: 5,556,619 →
Application: 08/202,395 →
Pharmaceutical Formulations of Cyclic Urea Type Compounds
Patent: 5,559,110 →
Application: 08/208,243 →
Derivatives of Cyclic Ethers and Sulfides for the Treatment of Atherosclerosis
Patent: 5,491,152 →
Application: 08/216,723 →
Amides for the Treatment of Atherosclerosis
Patent: 5,583,147 →
Application: 08/216,724 →
Novel Polycyclic Systems, and Derivatives Thereof, as Neurotransmitter Release Enhancers Useful in the Treatment of Cognitive Disorders
Patent: 5,594,001 →
Application: 08/216,881 →
2-Carbocyclic and 2-Heterocyclic Quinoline-4-Carboxylic Acids and Salts Thereof Useful as Immunosuppressive Agents
Patent: 5,523,408 →
Application: 08/217,911 →
Radiolabeled Platelet Gpiib/Iiia Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
Patent: 5,879,657 →
Application: 08/218,861 →
Highly Water Soluble Bis-Naphthalimides Useful as Anticancer Agents
Patent: 5,488,110 →
Application: 08/219,596 →
Preparation of Cyclic Urea Compounds
Patent: 5,508,400 →
Application: 08/230,562 →
Processes for Preparing Bis-Naphthalimides Containing Amino-Acid Derived Linkers
Patent: 5,461,176 →
Application: 08/249,773 →
Process for the Preparation of Diamine Intermediates Useful in the Synthesis of Hiv Protease Inhibitors
Patent: 5,559,252 →
Application: 08/268,609 →
Method for Preparing Alkylating Agents and Their Use for Alkylating Cyclic Ureas
Patent: 5,637,780 →
Application: 08/268,610 →
Imtermidiates for the Preparation of Cyclic Urea
Patent: 5,466,797 →
Application: 08/268,702 →
Method for Preparing Cyclic Sulfamides and Their Use for the Synthesis of Hiv Protease Inhibitors
Patent: 5,506,355 →
Application: 08/269,281 →
Method for Preparing Cyclic Ureas and Their Use for the Synthesis of Hiv Protease Inhibitors
Patent: 5,530,124 →
Application: 08/269,320 →
Dihydroxypropylamine Containing Retroviral Protease Inhibitors
Patent: 5,491,149 →
Application: 08/296,998 →
(N-Phthalimidoalkyl)Piperidines
Patent: 5,480,892 →
Application: 08/298,268 →
Isoxazoline Compounds Useful as Fibrinogen Receptor Antagonists
Patent: 5,446,056 →
Application: 08/304,614 →
Process for the Isolation and Purification of Ester Functionalized Imidazole Intermediates by Selective Hydrolysis
Patent: 5,510,495 →
Application: 08/307,441 →
Disubstituted Polycyclic Systems as Cognition Enhancers
Patent: 5,532,249 →
Application: 08/312,488 →
Novel Prostaglandin Synthase Inhibitors
Patent: 5,593,994 →
Application: 08/314,991 →
Amidino and Guanidino Substituted Boronic Acid Inhibitors of Trypsin-Like Enzymes
Patent: 5,658,885 →
Application: 08/329,039 →
Cyclic Compounds Linked by a Heterocyclic Ring Useful as Inhibitors of Platelet Glycoprotein Iib/Iiia
Patent: 5,773,411 →
Application: 08/338,977 →
Aromatic Compounds Containing Basic and Acidic Termini Useful as Fibrinogen Receptor Antagonists
Patent: 5,563,158 →
Application: 08/343,159 →
Boronic Acid and Ester Inhibitors of Thrombin
Application: 08/348,029 →
Imidazole 5-Position Substituted Angiotensin Ii Antagonists
Patent: 5,545,651 →
Application: 08/348,843 →
Process for the Isolation and Purification of an Imidazole Steroisomer from a Mixture of Stereoisomers by Selective Precipitation
Patent: 5,519,143 →
Application: 08/360,248 →
Boronic Acid and Ester Inhibitors of Thrombin
Patent: 5,563,127 →
Application: 08/364,338 →
(2QUINOXALINYLOXY)Phenoxypropanoic Acids and Related Derivatives as Anticancer Agents
Patent: 5,696,119 →
Application: 08/367,481 →
Method for the Synthesis of Anthrapyrazolone
Patent: 5,618,944 →
Application: 08/370,933 →
Novel Processes and Intermediate Compounds for the Preparation of Platelet Glycoprotein Iib/Iiia Inhibitors
Patent: 5,817,749 →
Application: 08/371,624 →
Immunoassay Reagents and Methods for Detecting Brequinar and Analogs
Patent: 5,707,844 →
Application: 08/372,472 →
Blockade of Neuronal M-Channels as a Therapeutic Approach to the Treatment of Neurological Disease
Patent: 5,750,528 →
Application: 08/384,289 →
3-Aromatic and 3-Heteroaromatic Substituted Bisnaphthalimides
Patent: 5,641,782 →
Application: 08/389,603 →
Tris(Isonitrile) Copper(I) Sulfates for Preparing Radionuclide Complexes
Patent: 5,693,324 →
Application: 08/391,756 →
Pyridine Compounds
Patent: 5,519,132 →
Application: 08/392,017 →
Polycyclic and Heterocyclic Chromophores for Bis-Imide Tumoricidals
Patent: 5,585,382 →
Application: 08/392,018 →
Novel Neurotransmitter Releasers Useful for Cognition Enhancement
Patent: 5,532,247 →
Application: 08/392,648 →
4-Heteroaryl- 1,4-Dihydropyridine Compounds Calcium Agonist and ALPHA1-Antagonist Activity
Patent: 5,580,871 →
Application: 08/401,599 →
Cylic Urea Hiv Protease Inhibitors
Application: 08/406,240 →
Piperidine Containing Aminobornic Acids
Patent: 5,731,439 →
Application: 08/409,303 →
Imidazole Containing Aminoboronic Acids
Patent: 5,639,739 →
Application: 08/409,573 →
Carbocyclic and Heterocyclic Fused-Ring Quinolinecarboxylic Acids Useful as Immunosuppressive Agents
Patent: 5,639,759 →
Application: 08/411,251 →
Ternary Radiopharmaceutical Complexes
Patent: 5,744,120 →
Application: 08/415,908 →
Isoxazoline and Isoxazole Fibrinogen Receptor Antagonists
Patent: 5,849,736 →
Application: 08/455,436 →
Cyclic Compounds Useful as Inhibitors of Platelet Glycoprotein Iib/Iiia
Patent: 5,635,477 →
Application: 08/461,611 →
Method for Preparing N,N'-Disubstituted Cyclic Ureas
Patent: 5,532,356 →
Application: 08/469,409 →
Stable Hydrazones Linked to a Peptide Moiety as Reagents for the Preparation of Radiopharmaceuticals
Patent: 5,750,088 →
Application: 08/476,296 →
Method for Preparing N-Monosubstituted and N,N'-Disubstituted Unsymmetrical Cyclic Ureas
Patent: 5,532,357 →
Application: 08/481,683 →
2-Carbocyclic and 2-Heterocyclic Quinoline-4-Carboxylic Acids and Salts Thereof Useful as Immunosuppressive Agents
Patent: 5,578,609 →
Application: 08/510,933 →
Combination of a Opioid Antagonist and a Selective Serotonin Reuptake Inhibitor for Treatment of Alcoholism and Alcohol Dependence
Patent: 5,958,962 →
Application: 08/542,747 →
Processes and Intermediates for the Preparation of Cyclic Urea Hiv Protease Inhibitors
Patent: 5,710,286 →
Application: 08/557,254 →
Crosslinked Polymric Ammonium Salts
Patent: 5,726,284 →
Application: 08/604,212 →
1 Substituted Oxindoles and Azaoxindoles
Patent: 5,597,916 →
Application: 08/604,658 →
Aromatic Compounds Containing Basic and Acidic Termini Useful as Fibrinogen Receptor Antagonists
Patent: 5,739,163 →
Application: 08/612,597 →
Cylic Urea Hiv Protease Inhibitors
Patent: 5,683,999 →
Application: 08/613,554 →
Disubstituted Polycyclic Systems as Cognition Enhancers
Patent: 5,698,559 →
Application: 08/620,643 →
Hydroxamic Acid Compounds as Metalloprotease and Tnf Inhibitors
Patent: 5,703,092 →
Application: 08/632,863 →
Novel Hydroxamic and Carbocyclic Acids as Metalloprotease Inhibitors
Patent: 5,691,381 →
Application: 08/632,973 →
1,3,4-Thiadiazoles Anbd 1,3,4-Oxadiazoles as Iib/Iiia Antagonists
Patent: 5,668,159 →
Application: 08/643,438 →
Novel Integrin Receptor Antagonists
Patent: 5,710,159 →
Application: 08/647,132 →
Novel Polycyclic Systems, and Derivatives Thereof, as Neurotransmitter Release Enhancers Useful in the Treatment of Cognitive Disorders
Patent: 5,990,132 →
Application: 08/664,631 →
Process for the Preparation of Diamine Intermediates Useful in the Synthesis of Hiv Protease Inhibitors
Patent: 5,880,295 →
Application: 08/666,032 →
Stabilized Naloxone Formulations
Patent: 5,866,154 →
Application: 08/673,601 →
Novel Asymmetric Synthesis of R and S Warfarin and Its Analogs
Patent: 5,686,631 →
Application: 08/678,211 →
Boronic Acid and Ester Inhibitors of Thrombin
Patent: 5,698,538 →
Application: 08/690,220 →
Compounds Containing Basic and Acidic Termini Useful as Fibrinogen Receptor Antagonists
Patent: 5,691,329 →
Application: 08/694,043 →
Substituted Cyclic Ureas and Derivatives Thereof Useful as Retroviral Protease Inhibitors
Patent: 5,763,469 →
Application: 08/701,112 →
Radiopharmaceuticals for Imaging Infection and Inflammation
Application: 08/726,507 →
Novel Prostaglandin Synthase Inhibitors
Patent: 5,932,586 →
Application: 08/753,029 →
Isoxazoline, Isothiazoline and Pyrazoline Factor Xa Inhibitors
Patent: 5,939,418 →
Application: 08/768,908 →
Novel Integrin Receptor Antagonists
Patent: 5,760,028 →
Application: 08/770,538 →
Substituted Cyclic Carbonyls and Derivatives Thereof Useful as Retroviral Protease Inhibitors
Patent: 5,811,422 →
Application: 08/770,546 →
Method for Preparing Alkylating Agents for Their Use for Alkylating Cyclic Ureas
Patent: 5,877,312 →
Application: 08/777,645 →
99MTC-Tertiary-Butyl Isonitrile as Breast Tumor Imaging Agents
Patent: 5,961,952 →
Application: 08/785,399 →
A-Branched Anilines, Toluenes, and Analogs
Patent: 5,942,544 →
Application: 08/801,220 →
Process for Preventing Precipitation in Injection Solutions
Patent: 5,808,090 →
Application: 08/801,221 →
Ternary Radiopharmaceutical Complexes
Patent: 5,879,659 →
Application: 08/808,699 →
Spirocycle Integrin Inhibitors
Patent: 5,760,029 →
Application: 08/816,580 →
Aryloxy-And Arylthiosubstituted Pyrimidines and Triazines and Derivatives Thereof
Patent: 6,326,368 →
Application: 08/816,706 →
Carbocyclic and Hetertocyclicfused-Ring Quinolinecarboxylic Acids Osuseful as Immunosuppressive Agents
Patent: 5,874,441 →
Application: 08/820,222 →
Cyclic Compounds Linked by a Heterocyclic Ring Useful as Inhibitors of Platelet Glycoprotein Iib/Iiia
Patent: 5,849,693 →
Application: 08/820,424 →
Aryloxy- and Arylthio- Fused Pyridines and Pyrimidines and Derivatives
Patent: 6,124,300 →
Application: 08/822,257 →
Novel Asymmetric Synthesis of R-Alpha-Propyl-Piperonyl Amine and Its Analogs
Patent: 5,932,749 →
Application: 08/822,996 →
Arylamino Fused Pyridines and Pyrimidines
Patent: 6,107,300 →
Application: 08/823,029 →
N-Amidinophenyl) Cyclourea Analogs as Factor Xa Inhibitors
Patent: 5,925,635 →
Application: 08/838,246 →
4,4- Disubstituted -3,4- Dihydro-2(1H) Quinazolinones Useful as Hiv Reverse Transcriptase Inhibitors
Application: 08/838,540 →
4,4-Disubstituted-1, 4-Dihydro-2H-3, 1-Benzoxazin-2-Ones Useful as Reverse Transcriptase Inhibitors
Application: 08/846,578 →
Novel Macrocyclic Compounds as Metalloprotease Inhibitors
Patent: 6,281,352 →
Application: 08/856,223 →
Tetrahydropteridines for Treatment of Neurological Disorders
Patent: 6,083,948 →
Application: 08/857,349 →
Novel Corticotropin-Releasing Hormone Receptor
Patent: 5,888,811 →
Application: 08/861,249 →
Substitute Caprolactams and Derivatives Thereof Useful for Treatment of Hiv Disease
Patent: 5,877,170 →
Application: 08/862,560 →
New Ternary Ligand Complexes Useful as Radiopharmaceuticals
Patent: 6,403,054 →
Application: 08/864,586 →
Iontophoretic Delivery of Integrin Inhibitors
Patent: 6,185,453 →
Application: 08/877,829 →
Insulin Receptor Tyrosine Kinase Substrate
Patent: 5,891,674 →
Application: 08/878,563 →
Novel Guanidineas Factor Xa Inhibitors
Application: 08/878,884 →
Inhibitors of Factor Xa with a Neutral P1 Specificity Group
Application: 08/878,885 →
Oxygen or Sulfur Containing Heteroaromatics as Factor Xa Inhibitors
Application: 08/879,763 →
Nitrogen Containing Heteroaromtics as Factor Xa Inhibitors
Application: 08/879,944 →
Novel Process for Manufacturing Paroxetine Solid Dispersions
Patent: 5,955,475 →
Application: 08/885,068 →
Method for Preparing a- Chloroboronic Acids from Mannitol
Patent: 5,973,185 →
Application: 08/888,380 →
Amidinophenyl-Pyrrolidines, -Pyrrolines, and -Isoxazolidines and Derivatives Thereof
Patent: 6,057,342 →
Application: 08/888,718 →
Azolo Triazines and Pyrimidines
Patent: 6,124,289 →
Application: 08/899,242 →
Practical Synthesis of Benzoxazinones Useful as Hiv Reverse Transcriptase Inhibitors
Application: 08/900,016 →
Method of Treatment of Arterial and Venous Thromboembolic Disorders
Patent: 6,056,958 →
Application: 08/901,344 →
Electrophilic Peptide Analogs as Inhibitors of Trypsin-Like Enzymes
Patent: 6,060,462 →
Application: 08/904,881 →
1N-Alkyl-N-Arylpyrimidinamines and Derivatives Thereof
Patent: 6,107,301 →
Application: 08/906,349 →
Cyclic Carbamates and Isoxazolidines as Iib/Iia Antagonists
Application: 08/909,124 →
Amidinoindoles, Amidinoazoles, and Analogs Thereof
Patent: 5,886,191 →
Application: 08/916,736 →
Isoxazoline Fibrinogen Receptor Antagonists
Patent: 5,811,441 →
Application: 08/922,488 →
Pyrazinones and Triazinones and Their Derivatives Thereof
Patent: 6,159,980 →
Application: 08/929,935 →
Technetium-99M Labeled Chelator Incorporated Cyclic Peptides That Bind to the Gpiib/Iiia Receptor as Imaging Agents
Patent: 5,888,970 →
Application: 08/940,825 →
4,4-Disubstituted-1,4-Dihydro-2H-3,1-Benzoxazin-2-Ones Useful as Hiv Reverse Transcriptase Inhibtors and Intermediates and Processes for Making the Same
Patent: 5,874,430 →
Application: 08/942,031 →
Radiopharmaceuticals for Imaging Infection and Inflammation
Patent: 6,416,733 →
Application: 08/943,659 →
Novel Asymmetric R and S Warfarin and Its Analogs
Patent: 5,856,525 →
Application: 08/950,018 →
Stable Reagents for the Preparation of Radiopharmaceuticals
Patent: 6,015,904 →
Application: 08/956,313 →
Crosslinked Polymeric Ammonium Salts
Patent: 5,874,522 →
Application: 08/962,873 →
A1-(3-Aminoindazol-5-Yl)-3 Butyl-Cyclic Urea Useful as a Hiv Protease Inhibitor
Patent: 6,218,386 →
Application: 08/966,426 →
1-(3-Aminoindazol-5-Yl)-3-Phenylmethyl-Cyclic Ureas Useful as Hiv Protease Inhibitors
Patent: 5,932,570 →
Application: 08/966,491 →
Novel Isoxazoline and Isoxazole Fibrogen Receptor Antagonists
Patent: 6,114,328 →
Application: 08/978,295 →
Novel Integrin Receptor Antagonists
Patent: 6,130,231 →
Application: 08/980,016 →
Synthesis of Cyclopropylacetylene
Patent: 6,028,237 →
Application: 08/990,471 →
Nitrogen Containing Heteroaromatics as Factor Xa Inhibitors
Patent: 6,020,357 →
Application: 08/995,834 →
Phenyl-Isoxazoles as Factor Xa Inhibitors
Patent: 6,187,797 →
Application: 08/996,378 →
Radiolabeled Platelet Gpiib/Iiia Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
Patent: 6,022,523 →
Application: 08/999,400 →
1N-Alkyl-N-Arylpyrimidinamines and Derivatives Thereof
Patent: 6,342,503 →
Application: 09/004,150 →
Processes and Intermediates for the Preparation of Cyclic Urea Hiv Protease Inhibitors
Patent: 6,054,597 →
Application: 09/006,538 →
Ternary Radiopharmaceutical Complexes
Patent: 6,010,679 →
Application: 09/013,320 →
Triazines Bicyclic Compounds
Patent: 6,313,124 →
Application: 09/014,734 →
Azolo Triazines and Pyrimidines
Patent: 6,136,809 →
Application: 09/014,999 →
Azolo Triazines and Pyrimidines
Patent: 6,060,478 →
Application: 09/015,001 →
Azolo Triazines and Pyrimidines
Patent: 6,191,131 →
Application: 09/015,002 →
Method of Making Arylamino Triazolopyridines
Patent: 5,912,348 →
Application: 09/045,057 →
Dynamic Resolution of Isoxazoline Thioesters to Isoxazoline Carboxylic Acids
Patent: 6,022,977 →
Application: 09/047,555 →
Integrin Inhibitor Produrgs
Patent: 6,214,834 →
Application: 09/049,305 →
Indazoles of Cyclic Ureas Useful as Hiv Protease Inhibitors
Patent: 5,985,867 →
Application: 09/052,350 →
Apparatus for Holding Small Volumes of Liquids
Patent: 6,027,695 →
Application: 09/053,287 →
Asymmetric Synthesis of Benzoxazinones
Patent: 5,925,789 →
Application: 09/055,480 →
4,4-Disubstituted-3,4-Dihydro-2(1H)-Quinazolinones Useful as Hiv Reverse Transcriptase Inhibitors
Patent: 6,124,302 →
Application: 09/056,820 →
Novel Inhibitors of Peptide Binding to Mhc Class Ii Proteins
Application: 60/008,060 →
Amidinoindoles, Amidinoazoles, and Analogs Thereof
Application: 60/049,519 →
Use of Polymorphisms to Monitor Allelic Expression Levels
Application: 60/049,612 →
Crystalline Roxifiban
Application: 60/049,633 →
6-Membered Aromatics as Factor Xa Inhibitors
Application: 60/050,214 →
Inhibitors of Fxa with a Neutral P1 Specificity Group
Application: 60/050,219 →
Novel Guanidine Mimics as Factor Xa Inhibitors
Application: 60/050,265 →
Nitrogen Containing Heteroaromatics as Factor Xa Inhibitors
Application: 60/050,304 →
Oxygen or Sulfur Containing Heteroaromatics as Factor Xa Inhibtors
Application: 60/050,975 →
Imidazopyrimidines and Imidazopyridines for the Treatment 9F Neurological Disorders
Application: 60/051,628 →
Aryl-And Arylamino-Substituted Heterocycles as Corticotropin Releasing Hormone Antagonists
Application: 60/051,745 →
Preparation of Asymmetric Cyclic Ureas Using an Alkali Metal in Liquid Ammonia Process
Application: 60/051,866 →
Isolated Aggrecanase Proteins and an Aggrecanase Peptide Substrate-Based Assay System
Application: 60/053,850 →
Process for the Preparation of Cyclopropylacetylene
Application: 60/054,402 →
Isolated Aggrecanase Proteins and Aggaeczanse Peptide Substrate-Based Assay System
Application: 60/055,836 →
Novel Inhibitors of Aggrecanase and Matrix Metalloproteinases for the Treatment of Arthritis
Application: 60/055,944 →
Nitrogen Substituted Imidazo [4,5--C] Pyrazoles as Corticotropin Releasing Hormone Antagonists
Application: 60/056,735 →
Heterocyclyl-Substituted Ring-Fused Pyridines and Pyrimidines as Corticotropin Releasing Hormone(Crh) Antagonists, Useful for Treating Cns and Stress-Related Disorders
Application: 60/057,432 →
Benzimidazolinones, Benzoxazolinones, Benzopiperazinones, Indanones, and Derivatives Thereof as Inhibitors of Factor Xa
Application: 60/058,288 →
Intra-Coronary Radiation Devices Containing Ce-144 or Ru-106
Application: 60/060,805 →
Efficient Method for the Conversion of Nitriles to Amidines
Application: 60/061,707 →
Isolated Aggrecanase Proteins and an Aggrecanasepeptide Substrate-Based Assay System
Application: 60/062,169 →
Novel Lactam Metalloprotease Inhibitors
Application: 60/062,418 →
Radioactive Seeds for Brachytherapy and a Process for Making the Same
Application: 60/065,993 →
1,3,4-Thiadiazoles and 1,3,4-Oxadiazoles as AVB3 Antagonists
Application: 60/066,561 →
Novel Inhibitors of Aggrecanase and Matrix Metalloproteinases for the Treatment of Arthritis
Application: 60/068,335 →
Nitrogen Containing Heteroaromatics with Ortho-Substituted P1'S as Factor Xa Inhibitors
Application: 60/068,491 →
4,4-Disubstituted-3,4-Dihydro-2(1H) -Quinazolinones Useful as Hiv Reverse Transcriptase Inhibitors
Application: 60/071,322 →
Preparation of a Lipid Blend and a Phospholipid Suspension Containing the Lipid Blend
Application: 60/071,332 →
Assays for the Detection of Drug-Dependent Antibodies to Integrins
Application: 60/072,733 →
Novel Cyclic Sulfonamide Derivatives as Metalloproteinase Inhibitors
Application: 60/074,301 →
Oral Liquid Fprmulations of Benzoxazinones Hiv Reverse Transcriptase Inhibitors
Application: 60/074,880 →
Oral Liquid Formulations of Benzoxazinones Hiv Reverse Transcriptase Lmhinitors
Application: 60/074,881 →
Inhibitors of Fxa with a Neutral P1 Specificity Group
Application: 60/076,691 →
Crystalline 10, 10-Bis ( (2-Fluoro-4-Pyridinyl)Methyl)-9 (10H)- Anthracenone and an Improved Process for Preparing the Same
Application: 60/077,395 →
4,4-Disubstituted-3,4-Dihydro-2(1H)-Quinazolinthiones Useful as Hiv Reverse Transcriptase Inhibitors
Application: 60/079,653 →
Disubstituted Pyrazolines and Triazolines as Factor Xa Inhibitors
Application: 60/079,725 →
Oxime Ethers as Iib/Iiia Antagonists
Application: 60/080,145 →
Metallopharmaceuticals for the Imaging and Treatment of Cancer
Application: 60/080,150 →
Process for the Preparation of 10,10' Disubstituted Anthrones
Application: 60/080,223 →
Integrin Antagonists
Application: 60/080,242 →
Crystalline Roxifiban
Application: 60/080,278 →
Thiazolo[4,5-D]Pyrimidines and Pyridines as Corticotropin Releasing Factor (Crf) Antagonists
Application: 60/080,537 →
Imidazopyrimidines and Imidazopyridines for the Treatment of Neurological Disorders
Application: 60/080,665 →
Radiopharmaceuticals for Imaging Infection and Inflamation and for Imaging and Treatment of Cancer
Application: 60/080,672 →
Inorganic Materials for Radioactive Drug Delivery
Application: 60/080,719 →
Formulation of Fast-Dissolving Efavirenz Capsules or Tablets
Application: 60/080,925 →
Indeno (1,2-C ) Pyrazol-4- Ones Useful as Anti-Cancer and Anti-Proliferative Agents
Application: 60/082,476 →
Novel Substituted Aryl Hydroxamic Acids as Metalloproteinase Inhibitors
Application: 60/085,393 →
Novel Substituted Aryl Hydroxamic Acids as Metalloproteinase Inhibitors
Application: 60/085,394 →
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Oct 30, 1980
From: FINIZIO MICHAEL
To: E.I. DU PONT NEMOURS AND COMPANY, A CORP. OF DE.
Reel/Frame 003808/0664 →
Assignment of Assignors Interest. Nov 3, 1980
From: SMITH DEWEY H. JR.
To: E. I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE
Reel/Frame 003808/0647 →
Assignment of Assignors Interest. Nov 24, 1980
From: SCHMIDT, WILLIAM K.; VERNIER, VERNON G.; SMITH CHRISTINE; SMITH DEWEY JR.
To: E.I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE.
Reel/Frame 003849/0157 →
Assignment of Assignors Interest. Dec 29, 1980
From: CHERKOFSKY SAUL C.
To: E.I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 003817/0529 →
Assignment of Assignors Interest. Apr 3, 1981
From: DUDZINSKI JOHN R.; SCHMIDT WILLIAM K.
To: E. I. D PONT DE NEMOURS AND COMPANY
Reel/Frame 003842/0567 →
Assignment of Assignors Interest. Dec 11, 1981
From: BEREZIN, GILBERT H.; ALDRICH, PAUL EDWARD
To: E.I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE.
Reel/Frame 003933/0188 →
Assignment of Assignors Interest. May 3, 1982
From: HERMANN, EDWARD C.; LEE, KYU T.; MYERS, MELVYN J.
To: E.I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE
Reel/Frame 003980/0546 →
Assignment of Assignors Interest. Jul 16, 1982
From: RAJAGOPALAN, PARTHASARATHI
To: E.I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 004012/0019 →
Assignment of Assignors Interest. Nov 22, 1982
From: ENDO LABORATORIES, INC., A CORP. OF DEL.
To: E.I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 004063/0107 →
Assignment of Assignors Interest. Aug 31, 1983
From: CHERKOFSKY, SAUL C.
To: E.I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE
Reel/Frame 004165/0183 →
Assignment of Assignors Interest. May 29, 1984
From: NEW ENGLAND NUCLEAR CORPORATION
To: E.I. DU PONT DE NEMOURS AND COMPANY, INCORPORATED
Reel/Frame 004267/0211 →
Assignment of Assignors Interest. Nov 14, 1991
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: DU PONT MERCK PHARMACEUTICAL COMPANY
Reel/Frame 005955/0010 →
Assignment of Assignor's Interest Aug 29, 1996
From: INTERX RESEARCH CORPORATION
To: MERCK & CO., INC.
Reel/Frame 008153/0685 →